Clinical trial
Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized…
NCT00446251 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00446251 |
|---|---|
| Title | Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant |
| Official title | The Highly Sensitized Patients: Effects of Rituximab and Mycophenolate Mofetil (MMF) On Anti-Human Leukocyte Antigen (HLA) Antibody Levels In Patients Awaiting Cadaveric Renal Transplant. |
| Lead sponsor | University of Washington, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Failure, Chronic, Diabetic Nephropathies, Glomerulonephritis, IGA, Hypertension, Renal |
| Intervention type | Drug |
| Interventions | Rituximab, Mycophenolate mofetil (MMF) |
| Enrollment | 14 |
| Start date | Dec 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Mar 12, 2007 |
| Last update posted | Apr 6, 2010 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: